Scalable Purification Strategies for Viral Vectors and Vaccines

BPI Contributor

September 26, 2019

20 Min View
Scalable Purification Strategies for Viral Vectors and Vaccines

Date: Sep 26, 2019

Duration: 20 Min

This webcast features: Mark A. Snyder, Ph.D., R&D Manager, Process Chromatography Applications, Bio-Rad Laboratories

Large-scale downstream processing of viruses can face a range of obstacles different from those of many biotherapeutics. These challenges mostly arise from the size and complexity of the virus, which can affect product purity and recovery. Improvements of purification tools are necessary to overcome these challenges and must be engineered for easy scalability to meet manufacturing demands. Dr. Mark Snyder will discuss the difficulties when developing purification strategies for vaccine production and gene therapy. Dr. Snyder will explore innovative resin designs and functionalities and examine recent case studies and current processes that benefit from these resins and purification strategies.

Webcast Overview

  • Designing tools to address challenges

  • Demonstration of benefits from novel designs

  • Discussion of current purification platforms

Watch the recorded webcast below.

You May Also Like